Heart Transplantation for Homozygous Familial Transthyretin (TTR) V122I Cardiac Amyloidosis
Open Access
- 1 May 2008
- journal article
- case report
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 8 (5), 1056-1059
- https://doi.org/10.1111/j.1600-6143.2008.02162.x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Human transthyretin in complex with iododiflunisal: structural features associated with a potent amyloid inhibitorBiochemical Journal, 2005
- Heart Transplantation in a 68-Year-Old Patient with Senile Systemic AmyloidosisAmerican Journal of Transplantation, 2005
- Cardiac transplantation for amyloid heart disease: The United Kingdom experienceThe Journal of Heart and Lung Transplantation, 2004
- Native state stabilization by NSAIDs inhibits transthyretin amyloidogenesis from the most common familial disease variantsLaboratory Investigation, 2004
- Tabulation of human transthyretin (TTR) variants, 2003Amyloid, 2003
- Long term results of heart transplantation in patients with amyloid heart diseaseHeart, 2001
- Cardiac Amyloidosis: Report of a Patient Heterozygous for the Transthyretin Isoleucine 122 VariantScandinavian Journal of Immunology, 1990
- Systemic senile amyloidosis. Identification of a new prealbumin (transthyretin) variant in cardiac tissue: immunologic and biochemical similarity to one form of familial amyloidotic polyneuropathy.JCI Insight, 1989
- Worsening of congestive heart failure in amyloid heart disease treated by calcium channel-blocking agentsThe American Journal of Cardiology, 1985
- Digoxin sensitivity in amyloid cardiomyopathy.Circulation, 1981